Letters HPV vaccines

UK needs vaccine to protect against HPV types causing recurrent respiratory papillomatosis

BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d6672 (Published 18 October 2011) Cite this as: BMJ 2011;343:d6672
  1. Michael P Rothera, president1,
  2. David M Albert, immediate past president1,
  3. Owain R Hughes, clinical research fellow2
  1. 1British Association for Paediatric Otorhinolaryngology (BAPO), UK
  2. 2University College London Institute of Child Health and Great Ormond Street Hospital, London, UK
  1. mprothera{at}aol.com

We are pleased that the Department of Health is reviewing which human papillomavirus (HPV) vaccine to use in the national immunisation programme.1 As Jit and colleagues state, deciding between the bivalent and the quadrivalent vaccine is not straightforward. We would like to contribute to the decision making process by highlighting our experience of treating …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe